{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Ambarnath",
      "state": "",
      "country": "India",
      "classification": "Class III",
      "openfda": {
        "application_number": [
          "ANDA215101"
        ],
        "brand_name": [
          "ACETAZOLAMIDE"
        ],
        "generic_name": [
          "ACETAZOLAMIDE"
        ],
        "manufacturer_name": [
          "Advagen Pharma Ltd"
        ],
        "product_ndc": [
          "72888-047",
          "72888-048"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "ACETAZOLAMIDE"
        ],
        "rxcui": [
          "197303",
          "197304"
        ],
        "spl_id": [
          "436010eb-a8b0-b2ef-e063-6394a90afedd"
        ],
        "spl_set_id": [
          "c24d31f0-a556-4e53-97a9-4e05e28ca40f"
        ],
        "package_ndc": [
          "72888-047-01",
          "72888-048-01"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0372888047010",
          "0372888048017"
        ],
        "nui": [
          "N0000175517",
          "N0000000235",
          "M0020790"
        ],
        "pharm_class_epc": [
          "Carbonic Anhydrase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Carbonic Anhydrase Inhibitors [MoA]"
        ],
        "pharm_class_cs": [
          "Sulfonamides [CS]"
        ],
        "unii": [
          "O3FX965V0I"
        ]
      },
      "product_type": "Drugs",
      "event_id": "95217",
      "recalling_firm": "Rubicon Research Private Limited",
      "address_1": "4 & K30 5 Plot No K - 30",
      "address_2": "",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the US",
      "recall_number": "D-0659-2024",
      "product_description": "AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India  NDC 72888-047-01",
      "product_quantity": "3,984 bottles",
      "reason_for_recall": "Discoloration",
      "recall_initiation_date": "20240824",
      "center_classification_date": "20240913",
      "report_date": "20240925",
      "code_info": "Lot # 30575HF1, exp. date, Nov 2026 NDC# 72888-047-01",
      "more_code_info": ""
    }
  ]
}